Carvajal-Hausdorf, D. E., Schalper, K. A., Pusztai, L., Psyrri, A., Kalogeras, K. T., Kotoula, V., . . . Rimm, D. L. (2015). Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer. J Natl Cancer Inst.
শিকাগো স্টাইলে সাইটেশনCarvajal-Hausdorf, Daniel E., Kurt A. Schalper, Lajos Pusztai, Amanda Psyrri, Konstantine T. Kalogeras, Vasiliki Kotoula, George Fountzilas, এবং David L. Rimm. "Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer." J Natl Cancer Inst 2015.
এমএলএ সাইটেশনCarvajal-Hausdorf, Daniel E., et al. "Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer." J Natl Cancer Inst 2015.